Menyhart, Otília; Pongor, Lőrinc Sándor; Győrffy, Balázs
(2019)
The immunotherapy agent pembrolizumab has been approved for gastric cancer (GC) patients with recurrent or advanced disease who are PD-L1 positive. Mutations in the primary lesion may drive the expression of immune targets ...